Non-injectable insulin market to reach $3.41 billion by 2030 at 9.8% cagr, driven by rising obesity and diabetes issues.
Read More
Mrna therapeutics cdmo market to reach $8.26 billion by 2030 at 11.7% CAGR, driven by growing burden of chronic and infectious diseases.
Read More
Mrna therapeutics market to reach $42.32 billion by 2030 at 3.3% CAGR, driven by increasing prevalence of long-lasting and communicable diseases.
Read More
Mrna cancer vaccines and therapeutics market to reach $141.51 billion by 2030 at 14.4% CAGR, driven by rising prevalence of cancer.
Read More
Morphine drugs market to reach $30.17 billion by 2030 at 5.3% CAGR, driven by increasing prevalence of chronic pain conditions.
Read More
The global montelukast sodium market to reach $6.33 billion by 2030 at 8.4% CAGR, driven by increasing prevalence of asthma.
Read More
Monoclonal antibody therapeutics market to reach $396.1 billion by 2030 at 11.9% CAGR, driven by rising prevalence of autoimmune diseases.
Read More
Monoclonal antibodies market to reach $464.39 billion by 2030 at 12.6% CAGR, driven by increasing prevalence of cost-efficient biosimilar monoclonal antibodies.
Read More
Molecular targeted therapy market to reach $107.64 billion by 2030 at 8.4% CAGR, driven by rise of personalized medicine.
Read More
Modular fill-finish micro-factory market to reach $2.96 billion by 2030 at 11.1% CAGR, driven by increasing demand for personalized medicines.
Read More